Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate

Ryuta Uraki; Mutsumi Ito; Maki Kiso; Seiya Yamayoshi; Kiyoko Iwatsuki-Horimoto; Yuri Furusawa; Yuko Sakai-Tagawa; Masaki Imai; Michiko Koga; Shinya Yamamoto; Eisuke Adachi; Makoto Saito; Takeya Tsutsumi; Amato Otani; Tetsuhiro Kikuchi; Hiroshi Yotsuyanagi; Peter J. Halfmann; Andrew Pekosz; Yoshihiro Kawaoka

doi:10.1016/S1473-3099(23)00070-1

Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate

Ryuta Uraki
, Mutsumi Ito
, Maki Kiso
, Seiya Yamayoshi
, Kiyoko Iwatsuki-Horimoto
, Yuri Furusawa
, Yuko Sakai-Tagawa
, Masaki Imai
, Michiko Koga
, Shinya Yamamoto
, Eisuke Adachi
, Makoto Saito
, Takeya Tsutsumi
, Amato Otani
, Tetsuhiro Kikuchi
, Hiroshi Yotsuyanagi
, Peter J. Halfmann
, Andrew Pekosz
, Yoshihiro Kawaoka

Bloomberg School of Public Health

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	402-403
Number of pages	2
Journal	The Lancet Infectious Diseases
Volume	23
Issue number	4
DOIs	https://doi.org/10.1016/S1473-3099(23)00070-1
State	Published - Apr 2023

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1016/S1473-3099(23)00070-1

Cite this

Uraki, R., Ito, M., Kiso, M., Yamayoshi, S., Iwatsuki-Horimoto, K., Furusawa, Y., Sakai-Tagawa, Y., Imai, M., Koga, M., Yamamoto, S., Adachi, E., Saito, M., Tsutsumi, T., Otani, A., Kikuchi, T., Yotsuyanagi, H., Halfmann, P. J., Pekosz, A., & Kawaoka, Y. (2023). Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate. The Lancet Infectious Diseases, 23(4), 402-403. https://doi.org/10.1016/S1473-3099(23)00070-1

Uraki, R, Ito, M, Kiso, M, Yamayoshi, S, Iwatsuki-Horimoto, K, Furusawa, Y, Sakai-Tagawa, Y, Imai, M, Koga, M, Yamamoto, S, Adachi, E, Saito, M, Tsutsumi, T, Otani, A, Kikuchi, T, Yotsuyanagi, H, Halfmann, PJ, Pekosz, A & Kawaoka, Y 2023, 'Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate', The Lancet Infectious Diseases, vol. 23, no. 4, pp. 402-403. https://doi.org/10.1016/S1473-3099(23)00070-1

@article{c59b7dd0a44544099d7caa58a6a6871a,

title = "Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate",

author = "Ryuta Uraki and Mutsumi Ito and Maki Kiso and Seiya Yamayoshi and Kiyoko Iwatsuki-Horimoto and Yuri Furusawa and Yuko Sakai-Tagawa and Masaki Imai and Michiko Koga and Shinya Yamamoto and Eisuke Adachi and Makoto Saito and Takeya Tsutsumi and Amato Otani and Tetsuhiro Kikuchi and Hiroshi Yotsuyanagi and Halfmann, \{Peter J.\} and Andrew Pekosz and Yoshihiro Kawaoka",

year = "2023",

month = apr,

doi = "10.1016/S1473-3099(23)00070-1",

language = "English (US)",

volume = "23",

pages = "402--403",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd",

number = "4",

}

TY - JOUR

T1 - Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate

AU - Uraki, Ryuta

AU - Ito, Mutsumi

AU - Kiso, Maki

AU - Yamayoshi, Seiya

AU - Iwatsuki-Horimoto, Kiyoko

AU - Furusawa, Yuri

AU - Sakai-Tagawa, Yuko

AU - Imai, Masaki

AU - Koga, Michiko

AU - Yamamoto, Shinya

AU - Adachi, Eisuke

AU - Saito, Makoto

AU - Tsutsumi, Takeya

AU - Otani, Amato

AU - Kikuchi, Tetsuhiro

AU - Yotsuyanagi, Hiroshi

AU - Halfmann, Peter J.

AU - Pekosz, Andrew

AU - Kawaoka, Yoshihiro

PY - 2023/4

Y1 - 2023/4

UR - https://www.scopus.com/pages/publications/85150159674

UR - https://www.scopus.com/pages/publications/85150159674#tab=citedBy

U2 - 10.1016/S1473-3099(23)00070-1

DO - 10.1016/S1473-3099(23)00070-1

M3 - Letter

C2 - 36773622

AN - SCOPUS:85150159674

SN - 1473-3099

VL - 23

SP - 402

EP - 403

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 4

ER -

Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this